A PRESCRIÇÃO DE BENZODIAZEPÍNICOS NO TRATAMENTO DE INSÔNIA EM IDOSOS: UMA REVISÃO SISTEMÁTICA
DOI:
https://doi.org/10.36557/2674-8169.2026v8n4p96-108Palavras-chave:
Insônia, Idoso, Benzodiazepínicos, Efeitos AdversosResumo
Com o envelhecimento da população, observa-se um aumento expressivo na prevalência de distúrbios do sono entre idosos, especialmente da insônia. Nesse cenário, o uso frequente de benzodiazepínicos como estratégia terapêutica passa a configurar um relevante problema de saúde pública, sobretudo diante dos efeitos prejudiciais associados ao uso prolongado desses fármacos. O presente estudo tem como objetivo analisar a prescrição de benzodiazepínicos no tratamento da insônia em idosos, discutir os riscos relacionados ao uso contínuo e avaliar estratégias de desprescrição, bem como alternativas não farmacológicas. Para isso, realizou-se uma revisão sistemática da literatura, com buscas nas bases PubMed, SciELO e LILACS, empregando descritores relacionados a “benzodiazepinas”, “idoso” e “insônia”, incluindo estudos publicados nos últimos cinco anos, nos idiomas português, inglês e espanhol. Desse modo, observa-se que o uso prolongado desses medicamentos está associado a impactos nocivos relevantes, especialmente no contexto de polifarmácia, evidenciando a necessidade de reavaliações periódicas aliadas à adoção de abordagens não farmacológicas, como a terapia cognitivo-comportamental para insônia. Ademais, ressalta-se a importância do fortalecimento de estratégias educativas voltadas à promoção de maior segurança e qualidade de vida da população idosa.
Palavras-chave: Insônia, Idoso, Benzodiazepínicos, Efeitos Adversos.
Downloads
Referências
ABBOUD, M. Vitamin D supplementation and sleep: a systematic review and meta-analysis of intervention studies. Nutrients, Basel, v. 14, n. 5, p. 1076, 2022. DOI: https://doi.org/10.3390/nu14051076.
BAHMAD, C. et al. Método clínico centrado na pessoa os desafios entre o modelo biomédico e a longitudinalidade na promoção social de saúde. Revista Educação em Saúde, v. 8, p. 290–293, 2020.
BREWSTER, G. S.; RIEGEL, B.; GEHRMAN, P. R. Insomnia in the Older Adult. Sleep Medicine Clinics, v. 17, n. 2, p. 233–239, 2022.
BRUNNER, Emily et al. The Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits. American Society of Addiction Medicine, 2025. https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/benzodiazepine-tapering-2025/bzd-tapering-document---final-approved-version-for-distribution-02-28-25.pdf?sfvrsn=5bdf9c81_1
BEDNARCZYK, E. et al. Stakeholders’ views on the use of psychotropic medication in older people: a systematic review. Age and Ageing, v. 51, n. 3, 1 mar. 2022.
CAPIAU, A.; HUYS, L.; VAN POELGEEST, E.; VAN DER VELDE, N.; PETROVIC,
M.; SOMERS, A.; EuGMS Task and Finish Group on FRIDs. Therapeutic dilemmas with benzodiazepines andZ-drugs: insomnia and anxiety disorders versus increased fall risk: a clinical review. European GeriatricMedicine, v. 14, n. 4, p. 697-708, Aug. 2023. DOI: 10.1007/s41999-022-00731-4.
COSSA, L. et al. Estudo sobre o uso de benzodiazepínicos em idosos. Brazilian Journal of Implantologyand Health Sciences, v. 6, n. 2, p. 923–936, 9 fev. 2024.
CURROW, David C.; AGAR, Meera R. Benzodiazepine prescribing in people with chronic obstructive pulmonary disease: clinical considerations. Drugs & Aging, v. 37, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32217064/. Acesso em: 9 mar. 2026.
CUCHI, F.; SÁ, C. A.; FERRETTI, F. K.. Fatores associados aos distúrbios do sono em idosos moradores do meio rural. Kairós-Gerontologia, [S. l.], v. 27, n. 2, 2024. DOI: 10.61583/kairs.v27i2.95. Disponível em: https://kairosgerontologia.com.br/index.php/kairos/article/view/95. Acesso em: 6 mar. 2025.
DE PAZ-MONTÓN, M. et al. Physical exercise programmes to improve insomnia or poor sleep quality in elderly people: systematic review and meta-analysis. Sleep Medicine Reviews, London, v. 73, 2025.
DURANTE, J. C. et al. Prolonged use of benzodiazepine in primary health care: evaluation of effectiveness, dependence and cognitive function. Expert Opinion on Drug Safety, 2025. https://doi.org/10.1080/14740338.2025.2567587
EVRARD, P. et al. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and
quantitative studies using the theoretical domains framework. Implementation Science, v. 17, n. 1, 8 jul. 2022.
FORGERINI, M. et al. Drug interactions for elderly people with mental and behavioral disorders: a systematicscoping review. Archives of Gerontology and Geriatrics, v. 93, p. 104283, mar. 2021
FROST, R. et al. A scoping review of over-the-counter products for depression, anxiety and insomnia in older people. BMC Complementary Medicine and Therapies, London, v. 24, 2024.
VOM HOFE, I. et al. Benzodiazepine use in relation to long-term dementia risk and imaging markers of neurodegeneration: a population-based study. BMC Medicine, v. 22, n. 1, 2 jul. 2024. DOI: https://doi.org/10.1186/s12916-024-03437-5.KOZOLE SMID, A. K.; MLAKAR, A.; ŠTUKOVNIK, V. Toxicity of benzodiazepines in the treatment of insomnia disorders in older adults: a systematic literature review. Croatian medical journal, v. 65, n. 2, p. 146–155, 2024.
LEGRAND, D. et al. Association Between Benzodiazepines and Dementia: A Case-Control Study From Canadian Health Surveys and Medico-Administrative Databases. Journal of the Neurological Sciences, 2025. https://doi.org/10.1016/j.jns.2025.123746
LIU, L. et al. The Effects of Benzodiazepine Use and Abuse on Cognition in the Elders: A Systematic Review and Meta-Analysis of Comparative Studies. Frontiers in Psychiatry, v. 11, 17 set. 2020.
LIN, J.; ARNOVITZ, M.; KOTBI, N.; FRANÇOIS, D. Substance use disorders in the geriatric population: areview and synthesis of the literature on a growing problem in a growing population. Current Treatment Options in Psychiatry, p.1-20, Jun. 2023. DOI: 10.1007/s40501-023-00291-9. . C. A qualidade do sono no idoso. Disponível em:
<https://dspace.uevora.pt/rdpc/handle/10174/23272>. Acesso em: 22/02/2025.
MAH, J.; PITRE, T. Oral magnesium supplementation for insomnia in older adults: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies, London, v. 21, 2021.
MCEVOY, A. M. et al. Deprescribing benzodiazepine receptor agonists in older adults and people with cognitive impairment: a systematic review. Journal of the American Geriatrics Society, 2025. https://doi.org/10.1111/jgs.19512
MCEVOY, Gail K. et al. Deprescribing benzodiazepines in older adults: clinical implications and safety considerations. Drugs & Aging, 2025. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38892111/. Acesso em: 9 mar. 2026.
MORERA-FUMERO, A. L.; FERNANDEZ-LOPEZ, L.; ABREU-GONZALEZ, P. Melatonin and melatonin agonists as treatments for benzodiazepine and hypnotic dependence in primary insomnia patients: A systematic review. Drug and Alcohol Dependence, v. 212, 2020.
MYSLIWIEC, V. et al. The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines.Annals of Internal Medicine, v. 172, p. 325-336, 2020. DOI: 10.7326/M19-3575.
NIZNIK, J. D. et al. Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: A rapid review. Research in Social and Administrative Pharmacy, v. 18, n. 6, jul. 2021.
POLY, Thida N. et al. Association between benzodiazepine use and risk of hip fracture in elderly people: a meta-analysis of observational studies. Joint Bone Spine, v. 87, n. 2, p. 143-149, 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31980246/. Acesso em: 9 mar. 2026.
RIBEIRO, P. R. DE S.; SCHLINDWEIN, A. D. Benzodiazepine deprescription strategies in chronic users: a systematic review. Family Practice, 28 abr. 2021.
RIVAS, J. et al. Chronic use of benzodiazepine in older adults and its relationship with dementia: a systematic review and meta-analysis. Harvard Review of Psychiatry, 2024. https://doi.org/10.1097/hrp.0000000000000414
ROBERTSON, S.; PEACOCK, E. E.; SCOTT, R. Benzodiazepine use disorder: common questions and answers.American Family Physician, 2023.
ROBINSON, M. et al. Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review. npj Primary Care Respiratory Medicine, 2024.
SELLA, E. et al. Non-pharmacological interventions targeting sleep quality in older adults: a systematic review and meta-analysis. Aging & Mental Health, London, v. 27, n. 8, 2023.
VICTORRI-VIGNEAU, C. et al. Are seniors dependent on benzodiazepines? A national clinical survey of substance use disorder. Clinical Pharmacology and Therapeutics, 2021. https://doi.org/10.1002/cpt.2025
WANG, L.; PAN, Y.; YE, C.; GUO, L.; LUO, S.; DAI, S.; CHEN, N.; WANG, E. A
network meta-analysis of the long- and short-term efficacy of sleep medicines in adults and older adults. Neuroscience & Biobehavioral Reviews, v. 131, p.
-496, 2021. ISSN 0149-7634. DOI: 10.1016/j.neubiorev.2021.09.035.
WU, C.-C. et al. Benzodiazepine Use and the Risk of Dementia in the Elderly Population: An Umbrella Review of Meta-Analyses. Journal of Personalized Medicine, v. 13, n. 10, p. 1485, 12 out. 2023.
YOHANNES, A. M.; JIN, J. W.; KUNIK, M. E. Avaliação benefício-risco de drogas psicotrópicas em pacientes idosos com doença pulmonar obstrutiva crônica. Drugs & Aging, [S. l.], v. 39, n. 5, p. 323-332, maio 2022. DOI:
1007/s40266-022-00935-0. Disponível em: https://pubmed.ncbi.nlm.nih.gov/. Epub 19 abr. 2022. PMID: 35437683.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Pollyane Marcellino, Higo Kippert Motinho, Davi Arthur Bezerra de Lavor, Julia de Almeida Carvalho, Gracianny Gomes Martins
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os autores são detentores dos direitos autorais mediante uma licença CCBY 4.0.
